Iovance Biotherapeutics: updates corporate presentation

What happened Iovance Biotherapeutics, Inc. announced on Oct 5, 2026 that it updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others. A copy of the presentation is attached as Exhibit 99.1 and is incorporated herein by reference.

Key details

• Date of filing and update: Oct 5, 2026.
• The company "updated its corporate presentation" used at healthcare conferences and for analysts, current stockholders, and others.
• The presentation is attached as Exhibit 99.1.
• The 8-K reports Item 8.01 (Other events).

Why it may matter This filing reports Item 8.01 (Other events), which covers events the company chooses to disclose outside other specific 8-K categories; the filing attaches the updated corporate presentation as Exhibit 99.1. The filing does not show why the insider traded or why the company acted.